Endoscopic therapy may be more effective in long-term control of upper gastrointestinal angioectasias when compared with somatostatin analogues

Background and study aims: Bleeding secondary to upper gastrointestinal angioectasias requires medical intervention, hospitalization, and transfusions. Endoscopic and medical therapies have been used to treat upper gastrointestinal angioectasias. Therapeutic efficacy of treatment modalities used in management of upper gastrointestinal angioectasias, specifically short- and long-term outcomes, remains an area of interest. Patients and methods: This was a retrospective cohort study utilizing TriNetX. ICD codes were used to identify patients with angioectasias of the upper gastrointestinal tract with concomitant iron deficiency anemia, while excluding patients with other vascular lesions of the upper gastrointestinal tract. Patients were subsequently divided into two groups, endoscopic and medical therapy group. Results: At 6 months, patients receiving endoscopic therapy demonstrated lower rates of hospitalization (70% vs 88%, P < 0.001), need for esophagogastroduodenoscopy (EGD) (30% vs 48%, <i>P</i> <0.001), and all-cause mortality (12% vs 22%, <i>P</i> = 0.002). At 3 years, endoscopic therapy was still superior in terms of EGD burden (42% vs 56%, <i>P</i> = 0.001), hospitalization (83% vs 91%, <i>P</i> = 0.008), all-cause mortality (26% vs 38%, <i>P</i> = 0.003), and blood transfusion (35% vs 45%, <i>P</i> = 0.013). At the 5-year interval, endoscopic therapy continued to demonstrate a reduced need for EGDs, hospitalizations, blood transfusions, and all-cause mortality. Mean hemoglobin was higher in the endoscopic cohort compared to the medical therapy at all intervals. <b>Conclusions:</b> Endoscopic therapy alone may provide better short and long-term clinical outcomes for patients with upper gastrointestinal angioectasias as compared with medical therapy with somatostatin analogues alone. Multicenter randomized clinical trials will need to be performed to further validate these findings.

Authors

Institutions

Publication Details

Journal
Endoscopy International Open
Published
2026-05-11
DOI
https://doi.org/10.1055/a-2870-7610
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endoscopic therapy may be more effective in long-term control of upper gastrointestinal angioectasias when compared with somatostatin analogues

Christian S. Jackson, Mary Ayad, Muhammad Shikaib Shabbir
Endoscopy International Open
Gastrointestinal Bleeding Diagnosis and Treatment
article

Endoscopic therapy may be more effective in long-term control of upper gastrointestinal angioectasias when compared with somatostatin analogues

Christian S. Jackson, Mary Ayad, Muhammad Shikaib Shabbir
article en

Abstract

Background and study aims: Bleeding secondary to upper gastrointestinal angioectasias requires medical intervention, hospitalization, and transfusions. Endoscopic and medical therapies have been used to treat upper gastrointestinal angioectasias. Therapeutic efficacy of treatment modalities used in management of upper gastrointestinal angioectasias, specifically short- and long-term outcomes, remains an area of interest. Patients and methods: This was a retrospective cohort study utilizing TriNetX. ICD codes were used to identify patients with angioectasias of the upper gastrointestinal tract with concomitant iron deficiency anemia, while excluding patients with other vascular lesions of the upper gastrointestinal tract. Patients were subsequently divided into two groups, endoscopic and medical therapy group. Results: At 6 months, patients receiving endoscopic therapy demonstrated lower rates of hospitalization (70% vs 88%, P < 0.001), need for esophagogastroduodenoscopy (EGD) (30% vs 48%, <i>P</i> <0.001), and all-cause mortality (12% vs 22%, <i>P</i> = 0.002). At 3 years, endoscopic therapy was still superior in terms of EGD burden (42% vs 56%, <i>P</i> = 0.001), hospitalization (83% vs 91%, <i>P</i> = 0.008), all-cause mortality (26% vs 38%, <i>P</i> = 0.003), and blood transfusion (35% vs 45%, <i>P</i> = 0.013). At the 5-year interval, endoscopic therapy continued to demonstrate a reduced need for EGDs, hospitalizations, blood transfusions, and all-cause mortality. Mean hemoglobin was higher in the endoscopic cohort compared to the medical therapy at all intervals. <b>Conclusions:</b> Endoscopic therapy alone may provide better short and long-term clinical outcomes for patients with upper gastrointestinal angioectasias as compared with medical therapy with somatostatin analogues alone. Multicenter randomized clinical trials will need to be performed to further validate these findings.

Endoscopy International Open
University of California, Riverside (US), Jerry L. Pettis Memorial VA Medical Center (US)
Good health and well-being
Openalex Percentile: Top 5%
Gastrointestinal Bleeding Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.